Post by Logan on Apr 30, 2016 8:48:18 GMT -6
Indiana will receive $9.2 million from a New Jersey pharmaceutical maker to settle allegations that the drug company did not give the state the full rebate it owed Indiana Medicaid for prescription medications that treat stomach conditions.
The federal government and 34 other states will share in the $784.6 million settlement from Wyeth, a subsidiary of Pfizer Inc., for not charging state Medicaid programs the best price available for two proton-pump inhibitors, used to treat peptic ulcers and acid reflux disease.
It's the second largest settlement of its type in recent years, according to the Indiana attorney general’s office.
Under the federal Medicaid Prescription Drug Rebate Program, pharmaceutical companies are required to pay rebates four times a year to state Medicaid programs to ensure that states are charged the best price in the interest of conserving tax dollars.
Read more: www.thestarpress.com/story/news/2016/04/29/indiana-receive-92m-settled-medicaid-settlement/83704512/
The federal government and 34 other states will share in the $784.6 million settlement from Wyeth, a subsidiary of Pfizer Inc., for not charging state Medicaid programs the best price available for two proton-pump inhibitors, used to treat peptic ulcers and acid reflux disease.
It's the second largest settlement of its type in recent years, according to the Indiana attorney general’s office.
Under the federal Medicaid Prescription Drug Rebate Program, pharmaceutical companies are required to pay rebates four times a year to state Medicaid programs to ensure that states are charged the best price in the interest of conserving tax dollars.
Read more: www.thestarpress.com/story/news/2016/04/29/indiana-receive-92m-settled-medicaid-settlement/83704512/